Menyhart Otília, Kothalawala William Jayasekara, Győrffy Balázs
Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Hungarian Research Network, Budapest, 1117, Hungary.
National Laboratory for Drug Research and Development, Budapest, 1117, Hungary.
J Pharm Anal. 2025 May;15(5):101065. doi: 10.1016/j.jpha.2024.101065. Epub 2024 Aug 3.
The "hallmarks of cancer" concept provides a valuable framework for understanding fundamental organizing principles common to various cancers. However, without a consensus gene set for cancer hallmarks, data comparison and integration result in diverse biological interpretations across studies. Therefore, we aimed to form a consensus cancer hallmark gene set by merging data from available mapping resources and establishing a framework for mining these gene sets. By consolidating data from seven projects, 6763 genes associated with 10 cancer hallmarks were identified. A cancer hallmarks enrichment analysis was performed for prognostic genes associated with overall survival across 12 types of solid tumors. "Tissue invasion and metastasis" was most prominent in cancers of the stomach ( 2.2 × 10), pancreas ( 4.2 × 10), bladder ( 3.3 × 10), and ovaries ( 0.0007), aligning with their heightened potential to spread. "Sustained angiogenesis" was most prominent in squamous cell carcinomas of the lung ( 2.5 × 10), while "genome instability" showed strong enrichment in lung adenocarcinomas (LUADs) ( 1.5 × 10) and cancers of the liver ( 5.5 × 10), pancreas ( 2.1 × 10), and kidney ( = 0.018). Pancreatic cancers displayed the highest enrichment of hallmarks, emphasizing the disease's complexity, while in melanomas and cancers of the liver, prostate, and kidney, a single hallmark was enriched among the prognostic markers of survival. Additionally, an online tool (www.cancerhallmarks.com) that allows the identification of cancer-associated hallmarks from new gene sets was established. In summary, our aim of establishing a consensus list of cancer hallmark genes was achieved. Furthermore, the analysis of survival-associated genes revealed a unique pattern of hallmark enrichment with potential pharmacological implications in different tumor types.
“癌症特征”概念为理解各种癌症共有的基本组织原则提供了一个有价值的框架。然而,由于缺乏用于癌症特征的共识基因集,数据比较和整合导致不同研究之间产生了多样的生物学解释。因此,我们旨在通过合并来自现有映射资源的数据并建立挖掘这些基因集的框架,形成一个共识性的癌症特征基因集。通过整合七个项目的数据,鉴定出了与10个癌症特征相关的6763个基因。对12种实体瘤中与总生存相关的预后基因进行了癌症特征富集分析。“组织侵袭和转移”在胃癌(2.2×10)、胰腺癌(4.2×10)、膀胱癌(3.3×10)和卵巢癌(0.0007)中最为突出,这与它们较强的扩散潜力相符。“持续血管生成”在肺鳞状细胞癌(2.5×10)中最为突出,而“基因组不稳定”在肺腺癌(LUADs)(1.5×10)以及肝癌(5.5×10)、胰腺癌(2.1×10)和肾癌(=0.018)中显示出强烈富集。胰腺癌显示出最高的特征富集度,突出了该疾病的复杂性,而在黑色素瘤以及肝癌、前列腺癌和肾癌中,生存预后标志物中仅有一种特征富集。此外,还建立了一个在线工具(www.cancerhallmarks.com),可用于从新的基因集中识别与癌症相关的特征。总之,我们建立癌症特征基因共识列表的目标得以实现。此外,对生存相关基因的分析揭示了特征富集的独特模式,在不同肿瘤类型中具有潜在的药理学意义。